Donna Brown

Preclinical Efficacy of Bevacizumab with CRLX101, an Investigational Nanoparticle-Drug Conjugate, in Treatment of Metastatic Triple-Negative Breast Cancer.

R. Kerbel, S. Eliasof, Christina R. Lee, 2016, Cancer research.

Discovery of a Novel Cabazitaxel Nanoparticle-Drug Conjugate (CRLX522) with Improved Pharmacokinetic Properties and Anticancer Effects using a β-Cyclodextrin-PEG Copolymer-Based Delivery Platform.

S. Eliasof, S. Svenson, S. Tripathi, 2019, Journal of medicinal chemistry.

Preclinical Efficacy of Bevacizumab with CRLX101, an Investigational Nanoparticle-Drug Conjugate, in Treatment of Metastatic Triple-Negative Breast Cancer.

R. Kerbel, S. Eliasof, Christina R. Lee, 2016, Cancer research.